Swedish DPI company Iconovo has announced a licensing and development deal with generics manufacturer Amneal Pharmaceuticals for a generic dry powder asthma/COPD therapy delivered by Iconovo's ICOres multidose DPI. According to the company, the deal includes an undisclosed upfront payment and "milestone payments in the mid-single digit Euro millions range." Iconovo … [Read more...] about Iconovo signs licensing and development deal with Amneal Pharmaceuticals
Products and Services
Phillips-Medisize Acquires Medicom Innovation Partner
Device developer and manufacturer Phillips-Medisize has acquired Danish device company Medicom Innovation Partner (formerly Bang & Olufsen Medicom) for an undisclosed amount. The company said that, "The addition of Medicom’s capabilities expands Phillips-Medisize’s end-to-end injectable and inhalation device innovation service solutions for biopharma customers, … [Read more...] about Phillips-Medisize Acquires Medicom Innovation Partner
Hovione opens office in Japan
Spray-drying and DPI specialist Hovione announced the opening a new sales and customer support office in Osaka, Japan, saying that "The new office underlines the importance of Japan for Hovione's business activities. Japan is a strategic market for Hovione where the company is growing both its off patent API and its contract manufacturing businesses. The new office … [Read more...] about Hovione opens office in Japan
Vectura partners with Propeller Health to develop connected inhalers
Vectura Group and Propeller Health have announced that they will partner to develop a connected version of Vectura's LOMI (lever-operated multi-dose inhaler) DPI using Propeller's digital technology. The LOMI device, which is based on Vectura's GyroHaler, uses blister strips to deliver up to 60 doses. According to the announcement, discussions are underway to … [Read more...] about Vectura partners with Propeller Health to develop connected inhalers
Merxin launches clear PET MDI cans for R&D work
Generic inhalation device developer Merxin has announced the launch of its MRX002 clear PET pMDI can, which allows developers to observe and model formulations in laboratory settings. According to the company, the cans are compatible with HFA, ethanol, PEG, and glycerol, and will work with commercially available valves. Merxin, which was launched in December 2015 … [Read more...] about Merxin launches clear PET MDI cans for R&D work
Aptuit acquires Kuecept
CRO Aptuit has acquired preclinical formulation specialist Kuecept Ltd, the company said. Both companies have extensive experience in respiratory drug delivery. Kuecept Founder and CEO Mark Saunders commented, “Since our inception in 2007, we have focused our efforts on the provision of flexible, cost effective and responsive preclinical R&D services. Through this … [Read more...] about Aptuit acquires Kuecept
Nanopharm announces launch of dissolution testing for inhaled drugs using its UniDose collection system
OINDP analysis and development specialist Nanopharm is now offering dissolution testing services using its proprietary UniDose aerosol collection apparatus, the company said. UniDose allows analysts to conduct dissolution testing that is independent of the collected dose. The system deposits the entire dose at a low impaction velocity onto a high surface area … [Read more...] about Nanopharm announces launch of dissolution testing for inhaled drugs using its UniDose collection system
3M DDS launches Intelligent Control Inhaler
3M Drug Delivery Systems has announced the launch of the 3M Intelligent Control Inhaler, a connected, breath-actuated inhaler that provides instructions to the patient via a screen integrated into the device and provides feedback to both the patient and health care providers via an associated app. According to the company, the inhaler minimizes inspiration errors … [Read more...] about 3M DDS launches Intelligent Control Inhaler
Mystic Pharmaceuticals gets patent for nose to brain delivery systems for CNS drugs
The United States Patent and Trademark Office has issued US Patent 9,248,076 B2, titled “Dose Dispensing Containers,” to Mystic Pharmaceuticals, the company has announced. The patent covers nose-to-brain delivery systems for therapies to treat brain disorders such as Alzheimer’s disease and traumatic brain injury using Mystic's VersiDoser and VRx2 blister packaging … [Read more...] about Mystic Pharmaceuticals gets patent for nose to brain delivery systems for CNS drugs
Aptar Pharma launches eDose counter for MDIs
Aptar Pharma has announced the launch of its new eDose counter for MDIs at RDD 2016. According to the company, the eDose counter can be used with any metering valve; the counter's sensor detects the MDI spray directly to minimize the risk of miscounts; and the device provides priming and medication reminders. Aptar Pharma Prescription Division President Jean-Marc … [Read more...] about Aptar Pharma launches eDose counter for MDIs